EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunity-metabolism-senescence axis in liver fibrosis: mechanistic insights, therapeutic targets, and translational opportunities

Yaxuan Cao, Yan Chen iD, Kwong Hang Paul Tam iD

Clinical Science · 2026

DOI: 10.1042/cs20261837 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, 2026. Verfasst von Yaxuan Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Cellular Senescence, Liver, Adaptive Immunity. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Macau Science and Technology Development Fund, Macau University of Science and Technology Faculty Research Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a dynamic and potentially reversible consequence of chronic liver injury, shaped by persistent inflammation, metabolic disturbance, and impaired tissue repair. Accumulating evidence indicates that, rather than operating as independent processes, immune activation, metabolic reprogramming, and cellular senescence are closely interconnected during fibrogenesis, jointly driving hepatic stellate cell (HSC) activation, ductular reaction, and excessive extracellular matrix deposition. In this review, we synthesize current understanding of how innate and adaptive immune responses, metabolic remodeling in hepatocytes and HSCs, and senescent cells with their senescence-associated secretory phenotype cooperatively sustain fibrotic progression, with particular emphasis on bidirectional and context-dependent cross-talk. We further highlight key regulatory nodes—including NF-κB, AMPK-mTOR, SIRT1/3, the NLRP3 inflammasome, and the YAP/TAZ pathway—that integrate signals across these interconnected pathways. Recent advances in multi-omics profiling, spatial transcriptomics, and organoid-based models have provided new opportunities to interrogate this integrated network at cellular and spatial resolution. From a translational perspective, therapeutic strategies targeting immunometabolic regulation, inflammasome activation, and cellular senescence, especially when combined with cell-type-specific intervention approaches, may offer promising avenues for restoring tissue homeostasis and reversing liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisCellular SenescenceLiverAdaptive ImmunityImmunity, InnateHumansAnimalsHepatic Stellate CellsSignal Transduction

Stichwörter der Autor:innen

cell-type–specific therapycellular senescencehepatic stellate cellsimmunomodulationliver fibrosismetabolic remodeling

Autor:innen und Institutionen

  • Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.
  • Precision Regenerative Medicine Research Centre, Medical Science Division, Macau University of Science and Technology, Macao 999078, China.
  • School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.

ORCID-Profile: Yan Chen, Kwong Hang Paul Tam

Förderung

  • Macau Science and Technology Development Fund
  • Macau University of Science and Technology Faculty Research Grants

Zitieren

APA

Cao, Y., Chen, Y., & Tam, K. H. P. (2026). Immunity-metabolism-senescence axis in liver fibrosis: mechanistic insights, therapeutic targets, and translational opportunities. Clinical Science. https://doi.org/10.1042/cs20261837

Vancouver

Cao Y, Chen Y, Tam KHP. Immunity-metabolism-senescence axis in liver fibrosis: mechanistic insights, therapeutic targets, and translational opportunities. Clinical Science. 2026. doi:10.1042/cs20261837

BibTeX
@article{Cao2026,
  author = {Cao, Yaxuan and Chen, Yan and Tam, Kwong Hang Paul},
  title = {Immunity-metabolism-senescence axis in liver fibrosis: mechanistic insights, therapeutic targets, and translational opportunities},
  journal = {Clinical Science},
  year = {2026},
  doi = {10.1042/cs20261837}
}
Kostenlos starten →